New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens?

Authors
Publication date
Publisher
Blackwell Publishing Ltd

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Newcastle University E-Prints

    redirect
    oaioai:eprints.ncl.ac.uk:272311
    Last time updated on 30/05/2021